Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roivant
Biotech
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Galapagos CEO eyes exit as spinout names leader. Longtime NIH leader set to retire as chief of staff. Lilly exec jumps to Zealand.
Darren Incorvaia
,
Zoey Becker
Apr 25, 2025 8:30am
Immunovant narrows R&D focus as Roivant execs join C-suite
Apr 21, 2025 10:00am
Immunovant posts phase 3 autoimmune win but won't seek approval
Mar 19, 2025 9:15am
Big Pharma layoff rounds jump 281% in 2024
Jan 3, 2025 3:29pm
Roivant’s midstage asset fails to show benefit in lung disease
Dec 3, 2024 10:32am
Pfizer closes R&D unit that spawned $7.1B anti-TL1A med
Apr 17, 2024 7:00am
